世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000042803

キャリアスクリーニング市場 (2025年 - 2033年)

Grand View Research Inc.

Carrier Screening Market (2025 - 2033)

発刊日 2025/10

言語英語

体裁PDF/150ページ

ライセンス/価格150ページ

0000042803

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

規模、シェア、動向分析レポート:病状別 (脊髄性筋萎縮症、嚢胞性線維症、テイサックス病、ゴーシェ病、鎌状赤血球症)、タイプ別、技術別、最終用途別、地域別、およびセグメント予測

キャリアスクリーニング市場の概要

世界のキャリアスクリーニングの市場規模は、2024年に15億3,224万米ドルと推定され、2025年から2033年にかけて11.95%のCAGRで成長し2033年までに40億4,529万米ドルに達すると予測されます。遺伝性疾患の有病率の上昇、遺伝子検査の技術進歩、意識の高まり、個別化医療の需要が、市場の成長を促進する主な要因です。

レポート詳細

目次

Table of Contents

Chapter 1. Carrier Screening Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Medical Conditions
1.1.1.2. Type Segment
1.1.1.3. Technology Segment
1.1.1.4. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. Carrier Screening Market: Executive Summary
2.1. Market Snapshot
2.2. Medical Conditions
2.3. Type Snapshot
2.4. Technology Snapshot
2.5. End use Snapshot
2.6. Competitive Landscape Snapshot

Chapter 3. Carrier Screening Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Rising prevalence of genetic disorders
3.4.2. Technological advancements in genetic testing
3.4.3. Growing awareness and demand for personalized medicine
3.5. Market Restraint Analysis
3.5.1. Limited implementation of public health screening
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis

Chapter 4. Carrier Screening Market: Medical Conditions Estimates & Trend Analysis
4.1. Carrier Screening Market: Medical Conditions Movement Analysis
4.2. Spinal Muscular Atrophy
4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3. Cystic Fibrosis
4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Tay-Sachs
4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Gaucher Disease
4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Sickle Cell Disease
4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Others
4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Carrier Screening Market: Type Estimates & Trend Analysis
5.1. Carrier Screening Market: Type Movement Analysis
5.2. Expanded Carrier Screening
5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3. Targeted Disease Carrier Screening
5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Carrier Screening Market: Technology Estimates & Trend Analysis
6.1. Carrier Screening Market: End Use Movement Analysis
6.2. DNA Sequencing
6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3. Polymerase Chain Reaction
6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Microarrays
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Other Technologies (MLPA, Genotyping, Enzyme Screening)
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Carrier Screening Market: End Use Estimates & Trend Analysis
7.1. Carrier Screening Market: End Use Movement Analysis
7.2. Hospitals
7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3. Laboratories
7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Physician Offices & Clinics
7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Other End Users
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Carrier Screening Market: Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Carrier Screening Market Estimates And Forecast, 2021 - 2033 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Carrier Screening Market, 2021 - 2033 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Reimbursement Scenario
8.2.2.5. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada Carrier Screening Market, 2021 - 2033 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Reimbursement Scenario
8.2.3.5. Competitive Scenario
8.2.4. Mexico
8.2.4.1. Mexico Carrier Screening Market, 2021 - 2033 (USD Million)
8.2.4.2. Key Country Dynamics
8.2.4.3. Regulatory Framework
8.2.4.4. Reimbursement Scenario
8.2.4.5. Competitive Scenario
8.3. Europe
8.3.1. Europe Carrier Screening Market, 2021 - 2033 (USD Million)
8.3.2. UK
8.3.2.1. UK Carrier Screening Market, 2021 - 2033 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Reimbursement Scenario
8.3.2.5. Competitive Scenario
8.3.3. Germany
8.3.3.1. Germany Carrier Screening Market, 2021 - 2033 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Reimbursement Scenario
8.3.3.5. Competitive Scenario
8.3.4. Spain
8.3.4.1. Spain Carrier Screening Market, 2021 - 2033 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Reimbursement Scenario
8.3.4.5. Competitive Scenario
8.3.5. France
8.3.5.1. France Carrier Screening Market, 2021 - 2033 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Reimbursement Scenario
8.3.5.5. Competitive Scenario
8.3.6. Italy
8.3.6.1. Italy Carrier Screening Market, 2021 - 2033 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Reimbursement Scenario
8.3.6.5. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark Carrier Screening Market, 2021 - 2033 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Reimbursement Scenario
8.3.7.5. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden Carrier Screening Market, 2021 - 2033 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Reimbursement Scenario
8.3.8.5. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway Carrier Screening Market, 2021 - 2033 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Reimbursement Scenario
8.3.9.5. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia-Pacific Carrier Screening Market, 2021 - 2033 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Carrier Screening Market, 2021 - 2033 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Scenario
8.4.2.5. Competitive Scenario
8.4.3. China
8.4.3.1. China Carrier Screening Market, 2021 - 2033 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Scenario
8.4.3.5. Competitive Scenario
8.4.4. India
8.4.4.1. India Carrier Screening Market, 2021 - 2033 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Scenario
8.4.4.5. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea Carrier Screening Market, 2021 - 2033 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Reimbursement Scenario
8.4.5.5. Competitive Scenario
8.4.6. Thailand
8.4.6.1. Thailand Carrier Screening Market, 2021 - 2033 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Reimbursement Scenario
8.4.6.5. Competitive Scenario
8.4.7. Australia
8.4.7.1. Australia Carrier Screening Market, 2021 - 2033 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Reimbursement Scenario
8.4.7.5. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Carrier Screening Market, 2021 - 2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Carrier Screening Market, 2021 - 2033 (USD Million)
8.5.2.2. Key Country Dynamics
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Scenario
8.5.2.5. Competitive Scenario
8.5.3. Argentina
8.5.3.1. Argentina Carrier Screening Market, 2021 - 2033 (USD Million)
8.5.3.2. Key Country Dynamics
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Scenario
8.5.3.5. Competitive Scenario
8.6. Middle East & Africa
8.6.1. Middle East & Africa Carrier Screening Market, 2021 - 2033 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Carrier Screening Market, 2021 - 2033 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Scenario
8.6.2.5. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Carrier Screening Market, 2021 - 2033 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Scenario
8.6.3.5. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Carrier Screening Market, 2021 - 2033 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Scenario
8.6.4.5. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait Carrier Screening Market, 2021 - 2033 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Scenario
8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. NEW PRODUCT LAUNCH
9.2.2. PARTNERSHIPS
9.2.3. ACQUISITION
9.2.4. COLLABORATION
9.2.5. FUNDING
9.3. Key Company Market Share Analysis, 2024
9.4. Company Heat Map Analysis
9.5. Company Profiles
9.5.1. Myriad Genetics, Inc.
9.5.1.1. Company Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. BGI Genomics
9.5.2.1. Company Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. Illumina, Inc.
9.5.3.1. Company Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. Thermo Fisher Scientific, Inc
9.5.4.1. Company Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. F. Hoffmann-La Roche Ltd
9.5.5.1. Company Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Laboratory Corporation of America Holdings (LabCorp)
9.5.6.1. Company Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. Otogenetics Corporation
9.5.7.1. Company Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. MedGenome
9.5.8.1. Company Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. GeneTech (ATS Genetech Pvt Ltd)
9.5.9.1. Company Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. CENTOGENE GmbH
9.5.10.1. Company Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives

List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Carrier Screening Market, By Region, 2021 - 2033 (USD Million)
Table 4 Global Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 5 Global Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 6 Global Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 7 Global Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 8 North America Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
Table 9 North America Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 10 North America Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 11 North America Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 12 North America Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 13 U.S. Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 14 U.S. Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 15 U.S. Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 16 U.S. Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 17 Canada Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 18 Canada Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 19 Canada Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 20 Canada Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 21 Mexico Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 22 Mexico Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 23 Mexico Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 24 Mexico Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 25 Europe Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
Table 26 Europe Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 27 Europe Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 28 Europe Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 29 Europe Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 30 UK Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 31 UK Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 32 UK Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 33 UK Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 34 Germany Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 35 Germany Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 36 Germany Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 37 Germany Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 38 France Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 39 France Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 40 France Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 41 France Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 42 Italy Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 43 Italy Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 44 Italy Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 45 Italy Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 46 Spain Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 47 Spain Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 48 Spain Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 49 Spain Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 50 Sweden Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 51 Sweden Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 52 Sweden Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 53 Sweden Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 54 Norway Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 55 Norway Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 56 Norway Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 57 Norway Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 58 Denmark Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 59 Denmark Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 60 Denmark Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 61 Denmark Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 62 Asia Pacific Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 64 Asia Pacific Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 65 Asia-Pacific Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 66 Asia Pacific Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 67 Japan Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 68 Japan Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 69 Japan Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 70 Japan Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 71 China Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 72 China Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 73 China Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 74 China Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 75 India Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 76 India Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 77 India Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 78 India Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 79 Australia Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 80 Australia Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 81 Australia Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 82 Australia Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 83 Thailand Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 84 Thailand Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 85 Thailand Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 86 Thailand Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 87 South Korea Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 88 South Korea Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 89 South Korea Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 90 South Korea Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 91 Latin America Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
Table 92 Latin America Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 93 Latin America Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 94 Latin America Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 95 Latin America Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 96 Brazil Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 97 Brazil Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 98 Brazil Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 99 Brazil Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 100 Argentina Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 101 Argentina Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 102 Argentina Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 103 Argentina Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 104 MIDDLE EAST & AFRICA Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
Table 105 MIDDLE EAST & AFRICA Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 106 MIDDLE EAST & AFRICA Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 107 MIDDLE EAST & AFRICA Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 108 Middle East & Africa Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 109 South Africa Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 110 South Africa Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 111 South Africa Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 112 South Africa Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 116 Saudi Arabia Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 117 UAE Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 118 UAE Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 119 UAE Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 120 UAE Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
Table 121 Kuwait Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
Table 122 Kuwait Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
Table 123 Kuwait Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 124 Kuwait Carrier Screening Market, By End Use, 32021 - 2033 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global carrier screening market- Key market driver analysis
Fig. 7 Global carrier screening market - Key market restraint analysis
Fig. 8 Penetration & growth prospect mapping
Fig. 9 Global carrier screening market - Porter’s analysis
Fig. 10 Global carrier screening market - PESTEL analysis
Fig. 11 Global carrier screening market Medical Conditions outlook key takeaways
Fig. 12 Global carrier screening market: Medical Conditions movement analysis
Fig. 13 Spinal muscular Atrophy market estimates, 2021 - 2033 (USD Million)
Fig. 14 Cystic fibrosis market estimates, 2021 - 2033 (USD Million)
Fig. 15 Tay-Sachs market estimates, 2021 - 2033 (USD Million)
Fig. 16 Gaucher disease market estimates, 2021 - 2033 (USD Million)
Fig. 17 Sickle cell disease market estimates, 2021 - 2033 (USD Million)
Fig. 18 Others market estimates, 2021 - 2033 (USD Million)
Fig. 19 Global carrier screening market technology outlook key takeaways
Fig. 20 Global carrier screening market: technology movement analysis
Fig. 21 Expanded carrier screening market estimates, 2021 - 2033 (USD Million)
Fig. 22 Targeted disease carrier screening market estimates, 2021 - 2033 (USD Million)
Fig. 23 Global carrier screening market technology outlook key takeaways
Fig. 24 Global carrier screening market technology movement analysis
Fig. 25 DNA sequencing market estimates, 2021 - 2033 (USD Million)
Fig. 26 Polymerase chain reaction market estimates, 2021 - 2033 (USD Million)
Fig. 27 Microarrays market estimates, 2021 - 2033 (USD Million)
Fig. 28 Other technologies (MLPA, genotyping, enzyme screening) market estimates, 2021 - 2033 (USD Million)
Fig. 29 Global carrier screening market end use outlook key takeaways
Fig. 30 Global carrier screening market end use movement analysis
Fig. 31 Hospitals market estimates, 2021 - 2033 (USD Million)
Fig. 32 Laboratories market estimates, 2021 - 2033 (USD Million)
Fig. 33 Physician offices & clinics market estimates, 2021 - 2033 (USD Million)
Fig. 34 Other end users market estimates, 2021 - 2033 (USD Million)
Fig. 35 Regional marketplace: Key takeaways
Fig. 36 Global Carrier Screening Market: Regional movement analysis
Fig. 37 North America Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 38 U.S. Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 39 Canada Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 40 Mexico Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 41 Europe Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 42 UK Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 43 Germany Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 44 France Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 45 Spain Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 46 Italy Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 47 Denmark Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 48 Sweden Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 49 Norway Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 50 Asia Pacific Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 51 Japan Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 52 China Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 53 India Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 54 South Korea Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 55 Australia Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 56 Thailand Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 57 Latin America Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 58 Brazil Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 59 Argentina Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 60 Middle East & Africa Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 61 South Africa Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 62 Saudi Arabia Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 63 UAE Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 64 Kuwait Carrier Screening Market, 2021 - 2033 (USD Million)
Fig. 65 Strategy framework

この商品のレポートナンバー

0000042803

最近見たレポート

2025〜2030年のアジア太平洋地域の血液学およびフローサイトメトリーデータベース:18カ国 - 分析装置および試薬、2025年のサプライヤーシェア、2025〜2030年の40アッセイの検査量および販売セグメント予測

2025-2030 Asia-Pacific Hematology and Flow Cytometry Database: 18 Countries--Analyzers and Reagents, 2025 Supplier Shares, 2025-2030 Test Volume and Sales Segment Forecasts for 40 Assays

2025/10/24

9,500 USD

2025〜2030年のシンガポールの血液学およびフローサイトメトリーデータベース - 分析装置および試薬、2025年のサプライヤーシェア、2025〜2030年の40アッセイの検査量および販売セグメント予測

2025-2030 Singapore Hematology and Flow Cytometry Database: Analyzers and Reagents, 2025 Supplier Shares, 2025-2030 Test Volume and Sales Forecasts for 40 Assays

2025/10/24

950 USD

2025〜2030年のアメリカのウイルス学、細菌学、寄生虫学、真菌学データベース - 100種類の感染症検査、2025年のサプライヤーシェア、2025〜2030年の検査別の数量および売上セグメント予測

2025-2030 U.S. Virology, Bacteriology, Parasitology and Mycology Database: 100 Infectious Disease Tests, 2025 Supplier Shares, 2025-2030 Volume and Sales Segment Forecasts by Test

2025/10/24

1,850 USD

2025〜2030年のヨーロッパのウイルス学、細菌学、寄生虫学、真菌学データベース:38カ国、100種類の感染症検査、2025年のサプライヤーシェア、2025〜2030年の検査別の数量および売上セグメント予測

2025-2030 Europe Virology, Bacteriology, Parasitology and Mycology Database: 38 Countries, 100 Infectious Disease Tests, 2025 Supplier Shares, 2025-2030 Volume and Sales Segment Forecasts by Test

2025/10/24

14,500 USD

2025〜2030年のヨーロッパのウイルス学、細菌学、寄生虫学、真菌学データベース:フランス、ドイツ、イタリア、スペイン、イギリス - 100種類の感染症検査、2025年のサプライヤーシェア、2025〜2030年の検査別の数量および売上セグメント予測

2025-2030 Europe Virology, Bacteriology, Parasitology and Mycology Database: France, Germany, Italy, Spain, UK--100 Infectious Disease Tests, 2025 Supplier Shares, 2025-2030 Volume and Sales Segment Forecasts by Test

2025/10/24

3,750 USD

2025〜2030年の韓国のウイルス学、細菌学、寄生虫学、真菌学データベース - 100種類の感染症検査、2025年のサプライヤーシェア、2025〜2030年の検査別の数量および売上セグメント予測

2025-2030 South Korea Virology, Bacteriology, Parasitology and Mycology Database: 100 Infectious Disease Tests, 2025 Supplier Shares, 2025-2030 Volume and Sales Forecasts by Test

2025/10/24

950 USD

TOP